“Ultimately, Tesla is asking investors to fund an aggressive infrastructure cycle: if its pivot into autonomous fleets and physical AI succeeds, the long-term upside is massive, but any regulatory or technological delays leave the stock vulnerable if judged solely on its core automotive margins”
Tesla Earnings Miss Despite Strong EV Sales; Elon Musk Preaches Robotaxi Caution
“I wouldn’t be surprised to see capital flow into medical stocks this year”
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
“I was pleased to see Pfizer’s commitment to reducing R&D expenses through prioritizing 4 key R&D engines”
S&P 500 Stock Pfizer Jumps As Cost-Cutting Bolsters Profit